Bio-Techne

TECH53

S&P500

$75.90arrow_drop_up0.80%$0.60

S&P500

TECH53

$75.90

arrow_drop_up0.80%$0.60

S&P500

Performance History

Key Stats
Open	$75.54
Prev. Close	$75.31
EPS	0.95

Next Earnings Date	Feb 14, 2025

	LOW	HIGH
Day Range	75.03	77.27
52 Week Range	51.79	85.57

Ratios







EPS	0.95

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Bio-Techne (TECH)

Bio-Techne Corp (TECH) is a leading provider of innovative life science tools and services. The company operates in two segments: Protein Sciences and Diagnostics. It offers a wide range of products, including antibodies, proteins, immunoassays, and RNA-sequencing kits, which are used by researchers and scientists worldwide. Bio-Techne's products are used in various applications, such as drug discovery, diagnostics, and personalized medicine. The company has a strong track record of innovation and has been awarded numerous patents for its technologies.

Bio-Techne Corp has a market cap of $15.4 billion and a PEG ratio of 2.86. Its stock price has shown strong performance over the past year, with a 52-week range of $160.52 to $317.82. The stock is currently trading at $295.68, near its all-time high. The company has a high trading volume, indicating strong investor interest. Bio-Techne Corp's financial performance has been impressive, with strong revenue growth and profitability. Its revenue for the last fiscal year was $893 million, with a net income of $210 million.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Charles R. Kummeth
Headquarters: Minneapolis
Employees: 3000
Exchange: NASDAQ

Keep an eye on Bio-Techne

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Bio-Techne's (TECH) price per share?

The current price per share for Bio-Techne (TECH) is $75.9. The stock has seen a price change of $0.61 recently, indicating a 0.81% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Bio-Techne (TECH)?

For Bio-Techne (TECH), the 52-week high is $85.57, which is 12.74% from the current price. The 52-week low is $51.79, the current price is 46.55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Bio-Techne (TECH) a growth stock?

Bio-Techne (TECH) has shown an average price growth of -2.46% over the past three years. It has received a score of 35 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bio-Techne as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Bio-Techne (TECH) stock price performance year to date (YTD)?

As of the latest data, Bio-Techne (TECH) has a year-to-date price change of -1.06%. Over the past month, the stock has experienced a price change of 1.5%. Over the last three months, the change has been -2.27%. Over the past six months, the figure is -0.21%. Looking at a longer horizon, the five-year price change stands at 46.63%.

help

Is Bio-Techne (TECH) a profitable company?

Bio-Techne (TECH) has a net income of $168.07M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 66.7% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.88% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.16B, with a revenue growth rate of 1.97%, providing insight into the company's sales performance and growth. The gross profit is $773.07M. Operating income is noted at $253.05M. Furthermore, the EBITDA is $351.42M.

help

What is the market capitalization of Bio-Techne (TECH)?

Bio-Techne (TECH) has a market capitalization of $12.04B. The average daily trading volume is 75.95, indicating the stock's liquidity and investor engagement.

News

EXOSOME

BIOMARKER

DRUG DELIVERY

REGENERATIVE MEDICINE

CHRONIC DISEASES

PERSONALIZED MEDICINE

Oct 29, 2024

Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight

CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs

Apoptosis Assays Market Projected to Expand at a CAGR of 8.5%, Elevating to a Valuation of USD 11.3 billion by 2034 | Analysis by Transparency Market Research Inc.

EPIGENETICS

DIAGNOSTICS

PERSONALIZED MEDICINE

PRECISION HEALTHCARE

Jul 23, 2024

[Latest] Global Epigenetics Diagnostic Market Size/Share - GlobeNewswire

[Latest] Global Glycomics Market Size/Share Worth USD 5.2 - GlobeNewswire